Importance of quick attainment of minimal disease activity for a positive impact on lives of patients with psoriatic arthritis

To compare patient-reported outcomes (PROs) from the first year to the third year between patients with psoriatic arthritis (PsA) who achieved minimal disease activity (MDA) in the first year after diagnosis and those who did not. Consecutive, newly diagnosed, patients with DMARD naïve PsA with olig...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatic & musculoskeletal diseases open 2022-12, Vol.8 (2), p.e002706
Hauptverfasser:	Snoeck Henkemans, Selinde V J, de Jong, Pascal H P, Luime, Jolanda J, Kok, Marc R, Tchetverikov, Ilja, Kasiem, Fazira R, Welby, Sarah, Prickett, Adam R, van der Helm-van Mil, Annette H M, Vis, Marijn
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Arthritis, Psoriatic - diagnosis Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - epidemiology Fatigue - drug therapy Fatigue - etiology Humans Psoriatic Arthritis Quality of Life Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!